<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02340585</url>
  </required_header>
  <id_info>
    <org_study_id>ATLAS</org_study_id>
    <nct_id>NCT02340585</nct_id>
  </id_info>
  <brief_title>Neuroform Atlas Stent System Study</brief_title>
  <acronym>ATLAS</acronym>
  <official_title>Safety and Effectiveness of the Treatment of Wide Neck, Intracranial, Saccular Aneurysms With the Next Generation Neuroform Stent System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Neurovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Neurovascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to demonstrate effectiveness and safety of the&#xD;
      Neuroform Atlas Stent System for use with bare metal embolic coils.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, multicenter, open-label, single arm trial designed to demonstrate&#xD;
      the potential treatment of wide neck, intracranial, saccular aneurysms with the Next&#xD;
      Generation Neuroform Stent System with any approved embolic coils currently on the market.&#xD;
      The study will evaluate the percent occlusion of the treated target lesion on angiography in&#xD;
      the absence of retreatment, or parent artery stenosis at the target location at 12 months.&#xD;
      Subjects with documented wide neck, intracranial, saccular aneurysms arising from a parent&#xD;
      artery may potentially benefit from stent assisted coiling, provided they meet the other&#xD;
      eligibility criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">June 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke or Death</measure>
    <time_frame>within 12 months of the index procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Complete aneurysm occlusion of the treated target lesion on 12 mnth angiography</measure>
    <time_frame>12 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>New or worsening major ipsilateral stroke as measured</measure>
    <time_frame>within 12 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device related serious adverse events</measure>
    <time_frame>within 12 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subarachnoid hemorrhage</measure>
    <time_frame>within 12 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aneurysm rupture</measure>
    <time_frame>within 12 months post procedure</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>Next Generation Neuroform Stent System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The Next Generation Stent System is a self-expanding, open cell, nitinol stent designed to provide support of the coil mass within the aneurysm and minimize stent deflection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Next Generation Neuroform Stent System</intervention_name>
    <description>The Next Generation Neuroform Stent System is pre-loaded on a stent delivery wire and protected by a transfer sheath. An accessory pouch containing an optional stabilizer may be attached to the proximal end of the stent delivery wire to facilitate handling and stabilization.</description>
    <arm_group_label>Next Generation Neuroform Stent System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is between 18 and 80 years of age&#xD;
&#xD;
          2. Documented wide neck (neck ≥ 4 mm or a dome-to-neck ratio of &lt; 2), intracranial,&#xD;
             saccular aneurysm arising from a parent vessel with a diameter of ≥ 2mm and ≤ 4.5 mm,&#xD;
             which will be treated with bare metal coils&#xD;
&#xD;
          3. Subject or legal representative is willing and able to provide informed consent&#xD;
&#xD;
          4. Subject is willing and able to comply with protocol follow-up requirements&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known multiple untreated cerebral aneurysms, other than non-target blister aneurysm,&#xD;
             infundibulum, or aneurysm measuring &lt;3mm for each of three dimensions assessed&#xD;
             (height, width, and depth) that will not require treatment during the study period&#xD;
&#xD;
          2. Target lesion is a blister aneurysm, infundibulum, or aneurysm measuring &lt;3mm for each&#xD;
             of three dimensions assessed (height, width, and depth)&#xD;
&#xD;
          3. Target aneurysm that will require an Investigator to intentionally leave a neck&#xD;
             remnant in order to preserve blood flow in a bifurcation or branch&#xD;
&#xD;
          4. Coiling or stenting of a non-target intracranial aneurysm within 30 days prior to&#xD;
             study treatment&#xD;
&#xD;
          5. Target aneurysm is in the anterior circulation proximal to the superior hypophyseal&#xD;
             ICA&#xD;
&#xD;
          6. Acute target aneurysm rupture less than 14 days prior to study treatment&#xD;
&#xD;
          7. Hunt and Hess score ≥ 3 or a premorbid mRS score ≥4&#xD;
&#xD;
          8. An admission platelet count of &lt;50,000, any known coagulopathy, or an International&#xD;
             Normalized Ratio (INR)&gt;3.0 without oral anticoagulation therapy&#xD;
&#xD;
          9. A known absolute contraindication to angiography&#xD;
&#xD;
         10. Evidence of active cancer, terminal illness or any condition which, in the opinion of&#xD;
             the treating physician, would/could prevent subject from completing the study (e.g., a&#xD;
             high risk of embolic stroke, atrial fibrillation, co-morbidities, psychiatric&#xD;
             disorders, substance abuse, major surgery ≤ 30 days pre-procedure, etc.)&#xD;
&#xD;
         11. Known absolute contraindication to the use of required study medications or agents&#xD;
             (e.g., heparin, aspirin, clopidogrel, and radiographic contrast agents, etc.)&#xD;
&#xD;
         12. Female subject who is pregnant or intends to become pregnant during the study&#xD;
&#xD;
         13. Moya-Moya disease, arteriovenous malformation(s), arteriovenous fistula(e),&#xD;
             intracranial tumor(s), or intracranial hematoma(s) (unrelated to target aneurysm)&#xD;
&#xD;
         14. Significant atherosclerotic stenosis, significant vessel tortuosity, vasospasm&#xD;
             refractory to medication, unfavorable aneurysm morphology or vessel anatomy, or some&#xD;
             other condition(s) that, in the opinion of the treating physician, would/could prevent&#xD;
             or interfere with access to the target aneurysm and/or successful deployment of the&#xD;
             Neuroform Atlas™ Stent&#xD;
&#xD;
         15. Previous treatment (e.g., surgery, stenting) in the parent artery that, in the opinion&#xD;
             of the treating physician, would/could prevent or interfere with successful use of the&#xD;
             Neuroform Atlas™ Stent System and/or successful adjunctive deployment of embolic coils&#xD;
&#xD;
         16. Previous stent-assisted coiling of the target aneurysm&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Osama Zaidat, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mercy Health - St. Vincent Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Jankowitz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cooper University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vascular Neurology of Southern California</name>
      <address>
        <city>Thousand Oaks</city>
        <state>California</state>
        <zip>91360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiology Imaging Associates</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiology Imaging Associates at Lutheran Medical Center</name>
      <address>
        <city>Wheat Ridge</city>
        <state>Colorado</state>
        <zip>80033</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyerly Neurosurgery</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WellStar Kennestone Hospital</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Research Foundation</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40506</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical School</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SSM DePaul Health Center</name>
      <address>
        <city>Bridgeton</city>
        <state>Missouri</state>
        <zip>63044</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SUNY University at Buffalo Neurosurgery/Gates Vascular Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mercy Health - St. Vincent Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43608</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Healthcare - Memphis Hospitals</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor St. Luke's Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>January 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2015</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Next Generation Neuroform Stent System</keyword>
  <keyword>Wide Neck, Intracranial, Saccular Aneurysms</keyword>
  <keyword>Cerebral Aneurysms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>July 29, 2021</submitted>
    <returned>August 25, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

